0000874015-24-000178.txt : 20240717 0000874015-24-000178.hdr.sgml : 20240717 20240717170235 ACCESSION NUMBER: 0000874015-24-000178 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20240715 FILED AS OF DATE: 20240717 DATE AS OF CHANGE: 20240717 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Diaz Allene M. CENTRAL INDEX KEY: 0001773314 ORGANIZATION NAME: FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 000-19125 FILM NUMBER: 241122844 MAIL ADDRESS: STREET 1: C/O ALLENA PHARMACEUTIALS, INC. STREET 2: ONEW NEWTON EXECUTIVE PARK SUITE 202 CITY: NEWTON STATE: MA ZIP: 02462 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: IONIS PHARMACEUTICALS INC CENTRAL INDEX KEY: 0000874015 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] ORGANIZATION NAME: 03 Life Sciences IRS NUMBER: 330336973 STATE OF INCORPORATION: CA FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 2855 GAZELLE COURT CITY: CARLSBAD STATE: CA ZIP: 92010 BUSINESS PHONE: 7609319200 MAIL ADDRESS: STREET 1: 2855 GAZELLE COURT CITY: CARLSBAD STATE: CA ZIP: 92010 FORMER COMPANY: FORMER CONFORMED NAME: ISIS PHARMACEUTICALS INC DATE OF NAME CHANGE: 19930328 4 1 edgardoc.xml PRIMARY DOCUMENT X0508 4 2024-07-15 0 0000874015 IONIS PHARMACEUTICALS INC IONS 0001773314 Diaz Allene M. 2855 GAZELLE COURT CARLSBAD CA 92010 1 0 0 0 1 Common Stock 2024-07-15 4 M 0 4677 0.0 A 17353 D Common Stock 2024-07-16 4 S 0 900 48.9379 D 16453 D Common Stock 2024-07-16 4 S 0 737 50.17 D 15716 D Restricted Stock Unit 0.0 2024-07-15 4 M 0 4677 0.0 D Common Stock 4677 4079 D Acquired pursuant to vesting and release of shares in accordance with a Restricted Stock Unit award. Shares sold pursuant to a Rule 10b5-1 Trading Plan adopted by the reporting person on May 3, 2023 The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $48.745 to $49.461 inclusive. The reporting person undertakes to provide to Ionis Pharmaceuticals, Inc. any security holder of Ionis Pharmaceuticals, Inc. or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnote (3) on this Form 4. The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $50.0825 to $50.245 inclusive. The reporting person undertakes to provide to Ionis Pharmaceuticals, Inc. any security holder of Ionis Pharmaceuticals, Inc. or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnote (4) on this Form 4. Each Restricted Stock Unit represents a contingent right to receive one share of Ionis common stock, or its equivalent cash value. Restricted Stock Units vest 100% on either the first anniversary of the date of grant or the next regularly scheduled annual meeting of stockholders of the Company, whichever occurs earlier, and are delivered to the reporting person on the July 15th following the vesting date. Upon vesting, the Restricted Stock Units will be paid in whole shares of Ionis common stock or cash as may be determined by the Company. By: Patrick R. O'Neil, attorney-in-fact For: Allene M. Diaz 2024-07-16